Phosphate → (5R)-3-(6-{2-[(4-aminobenzyl)oxy]ethoxy}hexyl)-5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one
반응식
[CH3:1][C:2]1([CH3:49])[O:7][C:6]2[CH:8]=[CH:9][C:10]([C@H:12]3[O:16][C:15](=[O:17])[N:14]([CH2:18][CH2:19][CH2:20][CH2:21][CH2:22][CH2:23][O:24][CH2:25][CH2:26][O:27][CH2:28][C:29]4[CH:34]=[CH:33][C:32]([N:35]=C(C5C=CC=CC=5)C5C=CC=CC=5)=[CH:31][CH:30]=4)[CH2:13]3)=[CH:11][C:5]=2[CH2:4][O:3]1.C([O-])(=O)C.[Na+].Cl.NO.P([O-])([O-])([O-])=O>CO>[NH2:35][C:32]1[CH:31]=[CH:30][C:29]([CH2:28][O:27][CH2:26][CH2:25][O:24][CH2:23][CH2:22][CH2:21][CH2:20][CH2:19][CH2:18][N:14]2[CH2:13][C@@H:12]([C:10]3[CH:9]=[CH:8][C:6]4[O:7][C:2]([CH3:1])([CH3:49])[O:3][CH2:4][C:5]=4[CH:11]=3)[O:16][C:15]2=[O:17])=[CH:34][CH:33]=1참가 물질
6
반응물 4
생성물 1
시약·촉매·용매 1
실험 절차
A solution of (5R)-5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-3-{6-[2-({4-[(diphenylmethylene)amino]benzyl}oxy)ethoxy]hexyl}-1,3-oxazolidin-2-one (860 mg) in MeOH (13 ml) was treated with sodium acetate (255 mg) followed by hydroxylamine hydrochloride (162 mg) and the mixture was stirred at 20° for 0.5 h. Phosphate buffer solution (30 ml, pH6.5) was added and the mixture was extracted with EtOAc. The combined extracts were dried (Na2SO4) and the solvent evaporated in vacuo. The residue was purified by SPE (silica, 10 g). Elution with EtOAc-cyclohexane (1:1) then (4:1) gave the title compound (321 mg). LCMS RT=3.18 min.
후처리
- extractionthe mixture was extracted with EtOAc
- dry with materialThe combined extracts were dried (Na2SO4)
- customthe solvent evaporated in vacuo
- customThe residue was purified by SPE (silica, 10 g)
- washElution with EtOAc-cyclohexane (1:1)
출처 및 근거
- ORD 기록
- ord-e996ae281ace4cb195f3f35c025e485e
- 출처 데이터셋
- uspto-grants-2011_07
- 특허 번호
- US07982067B2
반응 노트
불러오는 중…